Cargando…
Psychometric Properties of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson’s Disease
BACKGROUND: A composite measure that assesses both cognitive and functional abilities in Parkinson’s disease (PD) would be useful for diagnosing mild cognitive impairment (MCI) and PD dementia (PDD) and as an outcome measure in randomized controlled trials. The Clinical Dementia Rating Scale Sum of...
Autores principales: | Gallagher, Julia, Rick, Jacqueline, Xie, Sharon X., Martinez-Martin, Pablo, Mamikonyan, Eugenia, Chen-Plotkin, Alice, Dahodwala, Nabila, Morley, James, Duda, John E., Trojanowski, John Q., Siderowf, Andrew, Weintraub, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058172/ https://www.ncbi.nlm.nih.gov/pubmed/33386814 http://dx.doi.org/10.3233/JPD-202390 |
Ejemplares similares
-
Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia
por: Akhtar, Rizwan S., et al.
Publicado: (2017) -
Genetic prediction of impulse control disorders in Parkinson's disease
por: Weintraub, Daniel, et al.
Publicado: (2022) -
An Alzheimer’s Disease-Derived Biomarker Signature Identifies Parkinson’s Disease Patients with Dementia
por: Berlyand, Yosef, et al.
Publicado: (2016) -
Validating virtual administration of neuropsychological testing in Parkinson disease: a pilot study
por: Weintraub, Daniel, et al.
Publicado: (2023) -
Validating virtual administration of neuropsychological testing in Parkinson disease: a pilot study
por: Gallagher, Julia, et al.
Publicado: (2023)